Endoscopic retrograde cholangiopancreatography

GI Alliance Partners with Digestive Disease Consultants

Retrieved on: 
Thursday, January 6, 2022
Health, Environment, Patient, Physician, ERCP, Endoscopic retrograde cholangiopancreatography, Gastrointestinal disease, CEO, MD, EUS, GI, Partnership, List of Medknow Publications academic journals, IGG, Consultant, Medicine, Central Illinois

DALLAS, Jan. 6, 2022 /PRNewswire/ -- GI Alliance , the nation's largest independent gastroenterology services organization, is excited to announce its partnership with Digestive Disease Consultants, the leading provider of independent GI services providing quality care to patients in the Normal and Bloomington areas of Illinois.

Key Points: 
  • DALLAS, Jan. 6, 2022 /PRNewswire/ -- GI Alliance , the nation's largest independent gastroenterology services organization, is excited to announce its partnership with Digestive Disease Consultants, the leading provider of independent GI services providing quality care to patients in the Normal and Bloomington areas of Illinois.
  • This expansion complements GI Alliance's presence as the leading provider of independent GI care in the state and the Midwest.
  • Partnering with GI Alliance allows us to take advantage of the strong foundation established in Illinois.
  • "The physicians and staff at Digestive Disease Consultants are a terrific addition to our Midwest region practices," said Jim Weber, M.D., CEO of GI Alliance.

Endoscopic Retrograde Cholangiopancreatography Global Market to 2027 - Opportunity Analysis and Industry Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, June 11, 2021
Medical devices, Health, Clinical medicine, Medicine, Medical specialties, Cholangiopancreatography, Endoscopy, Retrograde, Endoscopic retrograde cholangiopancreatography

The "Endoscopic Retrograde Cholangiopancreatography Market by Product Type, Application and End User: Global Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Endoscopic Retrograde Cholangiopancreatography Market by Product Type, Application and End User: Global Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global endoscopic retrograde cholangiopancreatography market was valued at $1,212.94 million in 2019, and is projected to reach $1,876.75 million by 2027, registering a CAGR of 5.6% from 2019 to 2027.
  • By product type, the endoscopic retrograde cholangiopancreatography market is categorized into endoscopes, endotherapy devices, imaging systems, energy devices, and others.
  • This report entails a detailed quantitative analysis along with the current global endoscopic retrograde cholangiopancreatography market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.

Olympus Launches Two New ERCP Stone Management Devices

Retrieved on: 
Friday, October 30, 2020
Clinical medicine, Medicine, Medical specialties, Endoscopic retrograde cholangiopancreatography, Endoscopy, Cholangiopancreatography, Olympus Corporation, Laparoscopy, Common bile duct stone, Biloma

CENTER VALLEY, Pa., Oct. 30, 2020 /PRNewswire/ --Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today the launch of its StoneMasterV and VorticCatchV EndoTherapy devices, increasing efficiency in bile duct stone management and retrieval for endoscopic retrograde cholangiopancreatography (ERCP).

Key Points: 
  • CENTER VALLEY, Pa., Oct. 30, 2020 /PRNewswire/ --Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today the launch of its StoneMasterV and VorticCatchV EndoTherapy devices, increasing efficiency in bile duct stone management and retrieval for endoscopic retrograde cholangiopancreatography (ERCP).
  • Approximately 650,000 ERCP procedures are performed in the U.S. annually.
  • VorticCatchV is the newest addition to Olympus' comprehensive stone retrieval basket portfolio.
  • Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments.

Global Pancreatic and Biliary Stents Market Analysis (2015-2020) and Forecast (2020-2030) Model - Key Trends and Developments Resulting from the COVID-19 Pandemic

Retrieved on: 
Thursday, August 13, 2020
Medical specialties, Hepatology, Anatomy, Gastroenterology, Digestive system, Bile duct, Stent, Pancreatic duct, Bile, Endoscopic retrograde cholangiopancreatography, Biliary dyskinesia

DUBLIN, Aug. 13, 2020 /PRNewswire/ -- The "Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 13, 2020 /PRNewswire/ -- The "Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.
  • This market model is built to visualize quantitative market trends within General Surgery therapeutic area.
  • The Pancreatic and biliary stents market is mainly driven by the diseases resulting in the obstruction in bile or pancreatic ducts.
  • Key Inclusions of the market model are:
    Currently marketed Pancreatic and Biliary stent and evolving competitive landscape.

Pancreatic & Biliary Stents Market Model 2015-2030 (COVID-19 Impact) - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 11, 2020
Medical devices, Health, Medical specialties, Hepatology, Anatomy, Medicine, Digestive system, Bile duct, Stent, Pancreatic duct, Bile, Endoscopic retrograde cholangiopancreatography, Klatskin tumor

The "Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.
  • The Pancreatic and biliary stents market is mainly driven by the diseases resulting in the obstruction in bile or pancreatic ducts.
  • Key Inclusions of the market model are:
    Currently marketed Pancreatic and Biliary stent and evolving competitive landscape.
  • The model will enable you to:
    Understand the impact of COVID-19 on Pancreatic and Biliary stent market.

Cannabics Pharmaceuticals Appoints Dr. Dana Ben-Ami Shor (MD), Gastroenterologist, to its Scientific Board of Advisors

Retrieved on: 
Wednesday, August 5, 2020
Clinical medicine, Medicine, Medical specialties, Endoscopy, Diagnostic gastroenterology, Endoscopic retrograde cholangiopancreatography, Gastroenterology, Endoscopic ultrasound, Cholangiopancreatography, Tel Aviv Sourasky Medical Center, Michel Kahaleh, Todd Baron

Dr. Ben-Ami Shor is a recognized expert in invasive endoscopy and gastroenterology in the Sourasky Medical Center in Tel-Aviv, Israel.

Key Points: 
  • Dr. Ben-Ami Shor is a recognized expert in invasive endoscopy and gastroenterology in the Sourasky Medical Center in Tel-Aviv, Israel.
  • Dr. Ben-Ami Shor earned her M.D in 2009, graduating cum laude from the Sackler Faculty of Medicine, Tel Aviv University.
  • Additionally, Dr. Ben-Ami Shor is proficient in both diagnostic and therapeutic endoscopic ultrasound (EUS), and endoscopic retrograde cholangiopancreatography (ERCP).
  • For the latest updates on Cannabics Pharmaceuticals follow the Company on Twitter @Cannabics, Facebook @CannabicsPharmaceuticals, LinkedIn, and on Instagram @Cannabics_Pharmaceuticals.

Chinese Gastrointestinal (GI) Endoscopic Device Market, Forecast to 2026 - Projections for Colonoscope, Duodenoscope, Enteroscope, Ultrasound Endoscope, and Gastroscope Markets

Retrieved on: 
Wednesday, May 6, 2020
Medicine, Clinical medicine, Medical specialties, Diagnostic gastroenterology, Gastroenterology, Endoscopy, Endoscopic retrograde cholangiopancreatography, Capsule endoscopy, Cholangiopancreatography, Endoclip, Todd Baron

DUBLIN, May 6, 2020 /PRNewswire/ -- The "Gastrointestinal Endoscopic Device Market Report Suite | China | 2020-2026 | MedSuite" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 6, 2020 /PRNewswire/ -- The "Gastrointestinal Endoscopic Device Market Report Suite | China | 2020-2026 | MedSuite" report has been added to ResearchAndMarkets.com's offering.
  • Growth of the Chinese gastrointestinal endoscopic device market will likely be limited by the prevalence of government hospitals.
  • As government hospitals continually displace pricey, imported products with more affordable device that are locally produced, ASPs will consequently decline.
  • This report on the Chinese market for gastrointestinal (GI) endoscopic devices includes gastrointestinal endoscopes, capsule endoscopy, stenting and dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, endoscopic tissue sampling devices and hemostasis devices.

China Gastrointestinal Endoscopic Device Market 2020-2026 - Chinese Government has Started Purchasing GI Devices from Local Manufacturers, Rather Than Premium, International Companies - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 6, 2020
Medical devices, Health, Medicine, Clinical medicine, Medical specialties, Diagnostic gastroenterology, Gastroenterology, Endoscopy, Endoscopic retrograde cholangiopancreatography, Capsule endoscopy, Cholangiopancreatography, Esophagogastroduodenoscopy, Endoclip

The "Gastrointestinal Endoscopic Device Market Report Suite | China | 2020-2026 | MedSuite" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Gastrointestinal Endoscopic Device Market Report Suite | China | 2020-2026 | MedSuite" report has been added to ResearchAndMarkets.com's offering.
  • Growth of the Chinese gastrointestinal endoscopic device market will likely be limited by the prevalence of government hospitals.
  • On top of that, the government has started purchasing GI devices from local manufacturers, rather than premium, international companies.
  • This report on the Chinese market for gastrointestinal (GI) endoscopic devices includes gastrointestinal endoscopes, capsule endoscopy, stenting and dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, endoscopic tissue sampling devices and hemostasis devices.

Olympus and Amplifire Jointly Develop Digital Learning Platform Aimed at Improving Patient Safety

Retrieved on: 
Monday, February 24, 2020
Medicine, Clinical medicine, Diagnostic gastroenterology, Endoscopy, Endoscopic retrograde cholangiopancreatography, Olympus Corporation, Cholangiopancreatography, Gastroenterology

CENTER VALLEY, Pa., and BOULDER, Colo., Feb. 24, 2020 /PRNewswire/ --Olympus Corporation of the Americas and Amplifire today announced a partnership to improve patient safety with a new digital learning platform designed to improve duodenoscope reprocessing by technicians.

Key Points: 
  • CENTER VALLEY, Pa., and BOULDER, Colo., Feb. 24, 2020 /PRNewswire/ --Olympus Corporation of the Americas and Amplifire today announced a partnership to improve patient safety with a new digital learning platform designed to improve duodenoscope reprocessing by technicians.
  • The new digital learning platform will be specifically designed for reprocessing the Olympus TJF-Q180V duodenoscope, which is a complex medical endoscope used to perform endoscopic retrograde cholangiopancreatography (ERCP).
  • The course is being made available through Amplifire to Olympus duodenoscope customers in the U.S., at no additional cost.
  • In a world of rapidly evolving bacterial threats to patient wellbeing, Olympus is united with us in helping healthcare organizations elevate technical performance and patient safety."

U.S. FDA Clears GI Scientific’s ScopeSeal®, the Only Single-Use Disposable Device Indicated to Significantly Reduce Duodenoscope Contamination During ERCP Procedures

Retrieved on: 
Thursday, October 24, 2019
Biotechnology, FDA, Medical devices, Other Health, Health, Medicine, Medical specialties, Clinical medicine, Diagnostic gastroenterology, Endoscopic retrograde cholangiopancreatography, Endoscopy, Infection control, Sterilization

ScopeSeal is a single-use disposable infection control device that preserves duodenoscope optics and other key functionality while sealing the infection prone distal end of the Olympus duodenoscope used in ERCP (Endoscopic Retrograde Cholangio-Pancreatography) procedures.

Key Points: 
  • ScopeSeal is a single-use disposable infection control device that preserves duodenoscope optics and other key functionality while sealing the infection prone distal end of the Olympus duodenoscope used in ERCP (Endoscopic Retrograde Cholangio-Pancreatography) procedures.
  • ScopeSeal is the only device cleared for human use by the FDA that seals the elevator area of the scope and significantly reduces duodenoscope distal end contamination during use.
  • This is true regardless of whether high level disinfection or terminal sterilization is used to reprocess.
  • GI Scientific, LLC ( www.giscientific.com ) is a medical technology innovator, committed to improving patient outcomes by providing new innovations for gastrointestinal procedures.